Corrigendum to “Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models” [Translational Oncology volume 39 (2024) 101803]
Saved in:
Main Authors: | Yuncang Yuan, Jiawei Fan, Dandan Liang, Shijie Wang, Xu Luo, Yongjie Zhu, Nan Liu, Tingxiu Xiang, Xudong Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324003784 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway
by: Sisi Wei, et al.
Published: (2025-01-01) -
The Differential Expressions and Associations of Intracellular and Extracellular GRP78/Bip with Disease Activity and Progression in Rheumatoid Arthritis
by: Guoyin Liu, et al.
Published: (2025-01-01) -
Do wolframin, P-glycoprotein, and GRP78/BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity?
by: Simona Kurekova, et al.
Published: (2025-02-01) -
Association of serum and local GRP78 and CHOP expressions with disease progression in patients with non-traumatic osteonecrosis of femoral head
by: Peng Zhang, et al.
Published: (2025-01-01) -
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
by: Nan Li, et al.
Published: (2023-01-01)